Docmode Health Technologies IPO Date, GMP, Review, Price, Form & Market Lot Details

The Docmode Health Technologies IPO has begun on 25-January-2024. It will close on 31-January-2024. The Total IPO Size is 6.71 Crores. The company set its IPO price is 79 Rs Per Share. Basically, There are two basic categories in Docmode Health Technologies IPO Subscription 1) others 2) Retail Individual Investors (RIIs)

Docmode Health Technologies is established in 2017.

Docmode Health Technologies is provides integrated learning solutions for healthcare professionals and learners worldwide through online and offline learning models.

The company’s offline learning modules include conferences and workshops, while the online modules include courses developed by the company’s content development team or by medical institutions and medical associations (medical professional organizations) and experts/opinion leaders.

The company also provides a platform for interprofessional, cross-sector learning through panel discussions and courses, and users can utilize its performance assessment tools to improve their clinical acumen in daily medical practice.

The company offers a total of 87 certificate programs and is affiliated with over 35 medical associations and universities around the world.

Check :- Upcoming SME IPO 2024

Docmode Health Technologies IPO Promotor Holding

Paulson Paul Thazhathedath and Hans Albert Lewis are the promoters of the company.

Docmode Health Technologies IPO Date, Details & Price Band

IPO Opening Dates 25-January-2024
IPO Closing Dates 30-January-2024
Price Band 79 Rs
Fresh Issue 6.71 Crore
Total IPO size 6.71 Crore
Minimum bid (lot size) 1600 Shares
Face Value 10 INR Per Share
Listing On NSE SME

Docmode Health Technologies IPO Market Lot

The Docmode Health Technologies IPO minimum market lot is 1600 shares With 126,400 ₹ Amount per application.

Lot No of Shares Amount
Minimum 1 1600 126,400 Rs
Maximum 1 1600 126,400 Rs
S-HNI (Min) 2 3200 252,800 Rs

Restated Financial Record of the three year (Amt. in Lakhs)

Total Assets Total Revenue Profit After Tax
31-Mar-21 567.26 710.46 55.33
31-Mar-22 1,008.36 1,243.76 92.20
31-Mar-23 1,700.88 3,297.42 194.82

Docmode Health Technologies IPO GMP Grey Market Premium

Docmode Health Technologies IPO GMP Grey market premium has been started today. Check Latest Docmode Health Technologies IPO GMP Grey market premium, Kostak Rates and Subject to Sauda Price here.

Docmode Health Technologies IPO Prospectus

Docmode Health Technologies IPO
DRHP Download
RHP Download

Docmode Health Technologies IPO Reviews

AngelOne – Update Soon
Choice Broking – Update Soon
Prabhudas Lilladher – Update Soon

Docmode Health Technologies IPO Form Download

Docmode Health Technologies IPO is available on NSE Website as well as on our Portal. Please click here Docmode Health Technologies IPO form Download.

Docmode Health Technologies IPO Allotment Date & Details

Allotment Date 31-January-2024
Initiation of refunds 01-February-2024
Transfer of shares to Demat accounts 01-February-2024
Listing Date 02-February-2024
Check Allotment Status Click here
</td>

Registrar of Docmode Health Technologies IPO

BIGSHARE SERVICES PRIVATE LIMITED
Office No. S6 – 2, 6th Floor,
Pinnacle Business Park, Next to Ahura Centre,
Mahakali Cave Road, Andheri – [East], Mumbai – 400093, Maharashtra, India.
Tel No.: +91 22 6263 8200
Fax No.: +91 22 6263 8299
Email: [email protected]
Website: www.bigshareonline.com
Contact Person: Mr. Aniket Chindarkar
SEBI Registration No.: INR000001385

Docmode Health Technologies Contact Details

Docmode Health Technologies Limited
201, Kalpataru Plaza,
Rambaug Off Chincholi Bunder Road,
Malad Mumbai – 400064
Phone: +919920923338
Email: [email protected]
Website: https://docmode.org/

Docmode Health Technologies IPO Lead Managers

FEDEX SECURITIES PRIVATE LIMITED
B 7, 3rd Floor, Jay Chambers, Dayaldas Road, Vile Parle – [East],
Mumbai – 400 057, Maharashtra, India
Tel No.: +91 81049 85249
E-mail: [email protected]
Website: www.fedsec.in
Contact Person: Saipan Sanghvi
SEBI Registration Number: INM000010163
Investor Grievance E-Mail: [email protected]

Leave a Reply